Valneva SE (VALN)
6.13
-0.05
(-0.81%)
USD |
NASDAQ |
Apr 13, 16:00
6.20
+0.07
(+1.14%)
After-Hours: 04:49
Valneva EPS Diluted (Quarterly) : -0.6714 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Nicox SA | -- |
| DBV Technologies SA | -1.170 |
| Cellectis SA | -0.2621 |
| Transgene SA | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -58.22M |
| Revenue (Quarterly) | 55.51M |
| Total Expenses (Quarterly) | 113.72M |
| Enterprise Value | 635.87M |
| Gross Profit Margin (Quarterly) | 24.36% |
| Profit Margin (Quarterly) | -104.9% |
| Earnings Yield | -25.39% |
| Normalized Earnings Yield | -25.39 |